8.2.1 Costicosteroids Summary

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/25

encourage image

There's no tags or description

Looks like no tags are added yet.

26 Terms

1
New cards

Identify core goals of corticosteroid therapy in asthma/COPD.

Suppress airway inflammation, explain pharmacologic effects, and evaluate side effects and drug interactions.

2
New cards

Explain why inhaled delivery is preferred for asthma drugs.

Delivers drug directly to airways and limits systemic exposure.

3
New cards

List ideal features of inhaled drugs.

- High lung deposition

- high systemic clearance

- long lung residence time

- high receptor selectivity

- proper dosing

4
New cards

Describe fate of swallowed portion of inhaled drugs.

Undergo first-pass metabolism, reducing systemic exposure.

5
New cards

Name two endogenous corticosteroids.

Cortisol and cortisone.

6
New cards

Explain function of 11β‑hydroxysteroid dehydrogenase.

Converts cortisol to cortisone to prevent mineralocorticoid receptor activation.

7
New cards

List three metabolic effects of prolonged glucocorticoid activity.

- Insulin resistance

- muscle wasting

- hepatic steatosis.

8
New cards

Describe glucocorticoid effects in adipose tissue.

Promote lipolysis and central fat deposition.

9
New cards

State the main anti‑inflammatory mechanism of corticosteroids.

GR-mediated repression of NF‑κB, reducing inflammatory cytokines.

10
New cards

Describe the result of transrepression.

Lower TNFα, IL‑1β, and other pro‑inflammatory mediators.

11
New cards

Name inflammatory cells reduced by corticosteroids.

- T lymphocytes

- eosinophils

- mast cells

- macrophages

- dendritic cells.

12
New cards

Name structural cell effects of corticosteroids.

- Lower cytokines in epithelial cells

- less leak in endothelial cells

- more β2 receptors in smooth muscle

- less mucus from glands.

13
New cards

List systemic corticosteroids used for severe asthma.

- Prednisone

- prednisolone

- methylprednisolone.

14
New cards

Identify active form of prednisone.

Prednisolone.

15
New cards

Explain why systemic therapy has more side effects.

Higher plasma concentrations and lower clearance.

16
New cards

Name common inhaled corticosteroids.

- Beclomethasone

- budesonide

- fluticasone

- mometasone

- ciclesonide.

17
New cards

Name ICS that are prodrugs.

Beclomethasone dipropionate and ciclesonide.

18
New cards

State ICS role in persistent asthma.

Prevention of symptoms and long‑term maintenance.

19
New cards

Explain meaning of higher receptor binding affinity.

Greater potency.

20
New cards

Explain why ICS have fewer systemic effects.

Low oral bioavailability and high clearance.

21
New cards

Name common local ICS adverse effects.

- Dysphonia

- cough

- bronchospasm

- oropharyngeal candidiasis.

22
New cards

How to reduce oral candidiasis risk?

Rinse mouth after inhalation.

23
New cards

Name systemic ICS effects.

- Cortisol suppression

- growth inhibition

- reduced bone density

- skin thinning

- glaucoma.

24
New cards

Best strategy to minimize ICS adverse effects.

Lowest effective dose and proper inhalation technique.

25
New cards

Name potent CYP3A4 inhibitor increasing ICS levels.

Ketoconazole.

26
New cards

State interaction risk for systemic corticosteroids.

High because CYP3A4 inhibitors and inducers alter plasma levels.